Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Vaxcyte, Inc. (PCVX : NSDQ)

• Company Description    Vaxcyte Inc.is a biopharmaceutical company develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate and complex antigen-based vaccines. Vaxcyte Inc.is based in Foster City, California. Number of Employees: 158

• Price / Volume Information    Yesterday's Closing Price: $50.30 Daily Weekly Monthly 20 Day Moving Average: 652,584 shares Shares Outstanding: 93.71 (millions) Market Capitalization: $4,713.45 (millions) Beta: 0.96 52 Week High: $54.84 52 Week Low: $17.44 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.86% -1.99% 12 Week 30.82% 21.44% Year To Date 4.90% -4.58%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 825 INDUSTRIAL ROAD STE. 300 - SAN CARLOS,CA 94070 USA ph: 650-837-0111 fax: - investors@vaxcyte.com http://www.vaxcyte.com

• General Corporate Information    Officers Grant E. Pickering - Chief Executive Officer and Director Andrew Guggenhime - President and Chief Financial Officer Elvia Cowan - Senior Vice President; Finance Carlos Paya - Director Annie Drapeau - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 92243G108 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/23 Next Expected EPS Date: 08/14/23 Share - Related Items Shares Outstanding: 93.71 Most Recent Split Date: (:1) Beta: 0.96 Market Capitalization: $4,713.45 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.67 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.98 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/23

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.29 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -2.94% vs. Previous Quarter: 4.11% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/23 - -33.83 12/31/22 - -39.33 09/30/22 - -50.84 ROA 03/31/23 - -31.28 12/31/22 - -35.92 09/30/22 - -44.89 Current Ratio 03/31/23 - 15.94 12/31/22 - 23.26 09/30/22 - 9.41 Quick Ratio 03/31/23 - 15.94 12/31/22 - 23.26 09/30/22 - 9.41 Operating Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Net Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Pre-Tax Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Book Value 03/31/23 - 10.08 12/31/22 - 12.00 09/30/22 - 6.06 Inventory Turnover 03/31/23 - - 12/31/22 - - 09/30/22 - - Debt-to-Equity 03/31/23 - 0.00 12/31/22 - 0.00 09/30/22 - 0.00 Debt-to-Capital 03/31/23 - 0.00 12/31/22 - 0.00 09/30/22 - 0.00

Powered by Zacks Investment Research ©